You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ustekinumab

Showing 1 - 25 of 82
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ustekinumab Intensification in Crohn's Disease

Not yet recruiting
  • Crohn Disease
  • Ustekinumab
  • (no location specified)
Jan 29, 2023

Psoriasis, Chron's Disease Trial (Ustekinumab)

Not yet recruiting
  • Psoriasis
  • Chron's Disease
  • Ustekinumab
  • (no location specified)
Feb 2, 2023

Bullous Pemphigoid Trial in Reims (Ustekinumab)

Recruiting
  • Bullous Pemphigoid
  • Ustekinumab
  • Reims, France
    Damien JOLLY
Mar 15, 2022

Children With Crohn's Disease

Recruiting
  • Crohn's Disease
  • Ustekinumab
  • Burlington, Vermont
    ImproveCareNow, Inc.
Aug 12, 2022

Crohn Disease Trial in Zaventem (Ustekinumab)

Recruiting
  • Crohn Disease
  • Ustekinumab
  • Zaventem, Belgium
    Ingrid Arijs
Feb 9, 2022

Ustekinumab and Tofacitinib as Third Line Therapy inMulticenter

Completed
  • Ulcerative Colitis
  • Milano, Italy
    Mariangela Allocca
Feb 13, 2023

Ustekinumab in Participants Suffering From Inflammatory Bowel

Recruiting
  • Crohn Disease
  • Colitis, Ulcerative
  • Ustekinumab
  • Vandoeuvre les Nancy, France
    CHU de Nancy - Hôpital de Brabois
Aug 17, 2022

Symptomatic Stricturing Crohn's Disease

Not yet recruiting
  • Crohn Disease
  • +2 more
  • Ustekinumab
  • (no location specified)
May 22, 2022

Healthy Trial in Tempe, Lincoln, Salt Lake City (Ustekinumab)

Completed
  • Healthy
  • Ustekinumab
  • Tempe, Arizona
  • +2 more
Feb 22, 2022

Crohn Disease Trial in Baltimore, New York (Ustekinumab)

Recruiting
  • Crohn Disease
  • Ustekinumab
  • Baltimore, Maryland
  • +1 more
Jul 29, 2022

Crohn Disease Trial in Zaventem (Ustekinumab)

Recruiting
  • Crohn Disease
  • Ustekinumab
  • Zaventem, Belgium
    Ingrid Arijs
Mar 18, 2022

Psoriatic Arthritis Trial in Frankfurt am Main (Methotrexate, Ustekinumab, Placebo)

Completed
  • Psoriatic Arthritis
  • Frankfurt am Main, Hessia, Germany
    CIRI
Mar 1, 2022

Ichthyosis Trial in Chicago (Ustekinumab)

Recruiting
  • Ichthyosis
  • Ustekinumab
  • Chicago, Illinois
    Northwestern University/Lurie Children's Hospital
Apr 19, 2022

Healthy Trial in Rennes (Ustekinumab)

Completed
  • Healthy
  • Ustekinumab
  • Rennes, France
    Biotrial Rennes
Apr 3, 2022

Psoriasis Trial (risankizumab, ustekinumab, for risankizumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Juvenile Psoriatic Arthritis, Psoriasis, Arthritis, Juvenile Trial in United States (Ustekinumab)

Recruiting
  • Juvenile Psoriatic Arthritis
  • +2 more
  • Ustekinumab
  • Los Angeles, California
  • +7 more
Aug 17, 2022

Ustekinumab Assessing Efficacy and Healthcare Resource

Completed
  • Crohn Disease
  • Ustekinumab
  • Örebro, Sweden
    Universitetssjukhuset Örebro
Feb 11, 2022

Psoriasis Trial (risankizumab, for risankizumab, ustekinumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Uveitis Trial run by the NEI (Ustekinumab)

Completed
Has Results
  • Uveitis
  • Ustekinumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 4, 2021

Psoriasis Trial in Cleveland (Ustekinumab)

Not yet recruiting
  • Psoriasis
  • Ustekinumab
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Jul 6, 2022

Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)

Recruiting
  • Hematologic and Lymphocytic Disorder
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Placebo Administration
  • +3 more
  • Duarte, California
  • +3 more
Mar 16, 2022

Psoriasis Trial in Barcelona, Granada, Pontevedra (Brodalumab, Ustekinumab, Placebo)

Recruiting
  • Psoriasis
  • Barcelona, Spain
  • +2 more
Aug 24, 2022

Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic Trial in Worldwide (Ustekinumab)

Recruiting
  • Crohn Disease
  • +2 more
  • Ustekinumab
  • Atlanta, Georgia
  • +24 more
Aug 17, 2022

Symptom Improvement of Ulcerative Colitis AfterInduction Dose of

Active, not recruiting
  • Ulcerative Colitis
  • Ustekinumab
  • Bunkyo-ku, Japan
  • +23 more
Aug 17, 2022

Crohn Disease Trial in China (Ustekinumab)

Recruiting
  • Crohn Disease
  • Ustekinumab
  • Beijing, China
  • +28 more
Aug 17, 2022